Gardasil: from bench, to bedside, to blunder

Lancet. 2010 Mar 20;375(9719):963-4. doi: 10.1016/S0140-6736(09)62029-8.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Alphapapillomavirus
  • Centers for Disease Control and Prevention, U.S.
  • Child
  • Female
  • Health Services Accessibility
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Humans
  • Immunization Programs
  • Papillomavirus Vaccines / administration & dosage*
  • Socioeconomic Factors
  • United States / epidemiology
  • Uterine Cervical Neoplasms / diagnosis
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / prevention & control*
  • Uterine Cervical Neoplasms / virology
  • Vaccination / statistics & numerical data*
  • Young Adult

Substances

  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Papillomavirus Vaccines